Clinical Trial Update: EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the efficacy of melatonin for treating hypoxic-ischemic encephalopathy in neonates. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic Ischaemic Encephalopathy

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: University of Child Health Sciences and Children's Hospital, Lahore | Conditions: Hypoxic Ischaemic Encephalopathy (HIE) | Phase 2 | Status: ACTIVE_NOT_RECRUITING